Caris Life Sciences, Inc. (CAI) Institutional Ownership Changes & 13F Activity
Caris Life Sciences, Inc. (CAI). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Sixth Street Partners Management Company, L.P., Fmr Llc, Coatue Management Llc, Braidwell Lp, and Pointstate Capital Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Hsbc Holdings Plc | Buy | +9,601 | — | 9,601 | $260.65K | Q4 2025 | Mar 06, 2026 |
| Raymond James Financial Inc | Buy | +97,518 | — | 97,518 | $2.63M | Q4 2025 | Feb 18, 2026 |
| Newedge Advisors, Llc | Buy | +200 | — | 200 | $5.40K | Q4 2025 | Feb 18, 2026 |
| Sixth Street Partners Management Company, L.P. | Buy | +19,385,399 | — | 19,385,399 | $523.02M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +14,217,768 | — | 14,217,768 | $383.60M | Q4 2025 | Feb 17, 2026 |
| Coatue Management Llc | Buy | +9,819,992 | — | 9,819,992 | $264.94M | Q4 2025 | Feb 17, 2026 |
| Braidwell Lp | Buy | +7,816,142 | — | 7,816,142 | $210.88M | Q4 2025 | Feb 17, 2026 |
| Pointstate Capital Lp | Buy | +6,718,707 | — | 6,718,707 | $181.27M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +4,827,965 | — | 4,827,965 | $130.26M | Q4 2025 | Feb 17, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +3,837,964 | — | 3,837,964 | $103.55M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +3,652,647 | — | 3,652,647 | $98.55M | Q4 2025 | Feb 17, 2026 |
| Orbimed Advisors Llc | Buy | +3,116,011 | — | 3,116,011 | $84.07M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +3,113,956 | — | 3,113,956 | $84.01M | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +1,864,860 | — | 1,864,860 | $50.31M | Q4 2025 | Feb 17, 2026 |
| Balyasny Asset Management L.P. | Buy | +1,660,280 | — | 1,660,280 | $44.79M | Q4 2025 | Feb 17, 2026 |
| Longaeva Partners L.P. | Buy | +1,509,745 | — | 1,509,745 | $40.73M | Q4 2025 | Feb 17, 2026 |
| Ameriprise Financial Inc | Buy | +1,505,080 | — | 1,505,080 | $40.61M | Q4 2025 | Feb 17, 2026 |
| Canada Pension Plan Investment Board | Buy | +1,464,558 | — | 1,464,558 | $39.51M | Q4 2025 | Feb 17, 2026 |
| Perceptive Advisors Llc | Buy | +1,136,206 | — | 1,136,206 | $30.65M | Q4 2025 | Feb 17, 2026 |
| Fil Ltd | Buy | +1,122,775 | — | 1,122,775 | $30.29M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +1,122,748 | — | 1,122,748 | $30.29M | Q4 2025 | Feb 17, 2026 |
| Ghisallo Capital Management Llc | Buy | +845,332 | — | 845,332 | $22.81M | Q4 2025 | Feb 17, 2026 |
| Woodline Partners Lp | Buy | +723,163 | — | 723,163 | $19.51M | Q4 2025 | Feb 17, 2026 |
| Rock Springs Capital Management Lp | Buy | +687,500 | — | 687,500 | $18.55M | Q4 2025 | Feb 17, 2026 |
| Meridiem Capital Partners Lp | Buy | +278,063 | — | 278,063 | $7.50M | Q4 2025 | Feb 17, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +247,407 | — | 247,407 | $6.68M | Q4 2025 | Feb 17, 2026 |
| Lazard Asset Management Llc | Buy | +242,779 | — | 242,779 | $6.55M | Q4 2025 | Feb 17, 2026 |
| Holocene Advisors, Lp | Buy | +237,897 | — | 237,897 | $6.42M | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +206,993 | — | 206,993 | $5.58M | Q4 2025 | Feb 17, 2026 |
| Worldquant Millennium Advisors Llc | Buy | +188,861 | — | 188,861 | $5.10M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about CAI activity
Which institutional owners are buying CAI?
Institutional owners buying CAI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CAI activity?
"Buy" means an investor increased their reported position in CAI compared to the prior reporting period. This reflects growing exposure to Caris Life Sciences, Inc. (CAI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CAI increasing?
Institutional interest in CAI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CAI Institutional Insights
- CAI Overview
- CAI 13F Institutional Holders
- CAI Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CAI Insider Trading & SEC Form 4 Activity
- CAI Articles
- Top Institutional Investor Stock Rankings